The FSA Spy market buzz – 28 March 2025
JP Morgan Asset Management gets enhanced; Thailand wants some leverage; Natxis is surveying the world; A billionaire here, another there; Business social media lunacy; Andrew Carnegie’s wisdom and more.
HEAD-TO-HEAD: JP Morgan versus UBS
FSA compares two China mixed asset products: the JP Morgan China Income Fund and the UBS Key Selection China Allocation Opportunity Fund.
Fees
The JP Morgan fund has an ongoing charge figure (OCF) of 1.85% and the annual expenses of the UBS fund are slightly higher at 1.91%.
The median OCF for Asia mixed asset products is 1.6%, according to FE Fundinfo data.
Ng sees no reason to be concerned about the fees charged by either fund.
“Investing in China’s markets tends to be more expensive and requires greater research resources than for other markets in Asia-Pacific,” he said.
Related Stories
Promoted Content
-
Smartphones on wheels
-
China bonds: plugging the yield gap
-
Impact opportunities: investing to limit biodiversity loss
-
Riding the wave of alternative income amongst HNWIs in APAC
-
The future of mobility
-
Investment Ideas for 2021: Explore the untapped potential in China Small Companies
-
Accessing India’s tech future
-
Tap into Japan’s post-pandemic growth trends
-
Thematic investment series: Innovative transformation cuts across “old” and “new” economy companies
-
An investment opportunity for the coming decades: the environment
